Skip to main content

Why Fortune magazine’s ‘most admired’ companies likely won’t be among 2022’s best-performing stocks

Pfizer’s appearance on this year's list, for example, may be more of a curse than a blessing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.